Cargando…
Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130637/ https://www.ncbi.nlm.nih.gov/pubmed/35637047 http://dx.doi.org/10.1016/j.arcmed.2022.05.004 |
| _version_ | 1784713012652802048 |
|---|---|
| author | NORIS-GARCÍA, ELENA ROBINSON-AGRAMONTE, MARIA DE LOS ANGELES GONÇALVES, CARLOS-ALBERTO |
| author_facet | NORIS-GARCÍA, ELENA ROBINSON-AGRAMONTE, MARIA DE LOS ANGELES GONÇALVES, CARLOS-ALBERTO |
| author_sort | NORIS-GARCÍA, ELENA |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9130637 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91306372022-05-25 Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic NORIS-GARCÍA, ELENA ROBINSON-AGRAMONTE, MARIA DE LOS ANGELES GONÇALVES, CARLOS-ALBERTO Arch Med Res Letter to Editor Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. 2022-07 2022-05-25 /pmc/articles/PMC9130637/ /pubmed/35637047 http://dx.doi.org/10.1016/j.arcmed.2022.05.004 Text en © 2022 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editor NORIS-GARCÍA, ELENA ROBINSON-AGRAMONTE, MARIA DE LOS ANGELES GONÇALVES, CARLOS-ALBERTO Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic |
| title | Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic |
| title_full | Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic |
| title_fullStr | Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic |
| title_full_unstemmed | Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic |
| title_short | Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic |
| title_sort | utility of serum s100b as a marker in systemic lupus erythematosus patients during and after the sars-cov-2 pandemic |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130637/ https://www.ncbi.nlm.nih.gov/pubmed/35637047 http://dx.doi.org/10.1016/j.arcmed.2022.05.004 |
| work_keys_str_mv | AT norisgarciaelena utilityofserums100basamarkerinsystemiclupuserythematosuspatientsduringandafterthesarscov2pandemic AT robinsonagramontemariadelosangeles utilityofserums100basamarkerinsystemiclupuserythematosuspatientsduringandafterthesarscov2pandemic AT goncalvescarlosalberto utilityofserums100basamarkerinsystemiclupuserythematosuspatientsduringandafterthesarscov2pandemic |